Aptus Capital Advisors LLC Increases Stake in Cigna Group $CI

Aptus Capital Advisors LLC raised its holdings in shares of Cigna Group (NYSE:CI) by 100.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,889 shares of the health services provider’s stock after purchasing an additional 2,448 shares during the quarter. Aptus Capital Advisors LLC’s holdings in Cigna Group were worth $1,409,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CI. Massachusetts Financial Services Co. MA raised its position in shares of Cigna Group by 1.1% in the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after purchasing an additional 123,479 shares during the period. Dodge & Cox boosted its holdings in Cigna Group by 0.7% in the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock worth $2,958,893,000 after buying an additional 60,877 shares during the period. Norges Bank purchased a new position in Cigna Group in the 2nd quarter valued at approximately $1,110,426,000. Arrowstreet Capital Limited Partnership raised its holdings in Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after acquiring an additional 492,045 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in Cigna Group by 0.7% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock valued at $678,652,000 after acquiring an additional 15,014 shares during the period. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $271.50 on Monday. The stock has a market cap of $71.55 billion, a P/E ratio of 12.24, a PEG ratio of 0.94 and a beta of 0.27. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The business’s 50-day moving average price is $280.71 and its two-hundred day moving average price is $283.97. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is presently 28.13%.

Insiders Place Their Bets

In other news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Guggenheim reaffirmed a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. TD Cowen boosted their price objective on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Weiss Ratings reissued a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. Royal Bank Of Canada reduced their target price on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Finally, Robert W. Baird decreased their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $330.42.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.